T&R Biofab Co. Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.002x

T&R Biofab Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, T&R Biofab Co. Ltd (246710) has a cash flow conversion efficiency ratio of 0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩17.53 Million ≈ $11.88K USD) by net assets (₩11.31 Billion ≈ $7.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of T&R Biofab Co. Ltd (2015–2024)

Cash flow conversion efficiency of T&R Biofab Co. Ltd from 2015 to 2024. This chart illustrates how T&R Biofab Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View T&R Biofab Co. Ltd (246710) share price today for real-time trading data and today's change.

T&R Biofab Co. Ltd Cash Flow Conversion Ratio Explained

T&R Biofab Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

T&R Biofab Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of T&R Biofab Co. Ltd ranked by their cash flow conversion efficiency. Also see market value of T&R Biofab Co. Ltd for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
dMY Squared Technology Group Inc NYSE MKT:DMYY	1.695x
GAMBLING.COM GRP ON F:6WH	0.017x
Bangkok Dec-Con Public Company Limited BK:BKD	-0.006x
INmune Bio Inc NASDAQ:INMB	-0.323x
Townsquare Media Inc NYSE:TSQ	-0.040x
Cardlytics Inc NASDAQ:CDLX	1.409x
Hana Must SPAC 2 KQ:208370	0.013x
Ausquest Ltd AU:AQD	-0.031x

Annual Cash Flow Conversion Efficiency for T&R Biofab Co. Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of T&R Biofab Co. Ltd from 2015 to 2024. Review 246710 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩24.21 Billion ≈ $16.41 Million	₩-11.73 Billion ≈ $-7.95 Million	-0.485x	-117.11%
2023-12-31	₩31.20 Billion ≈ $21.14 Million	₩-6.96 Billion ≈ $-4.72 Million	-0.223x	-48.88%
2022-12-31	₩39.26 Billion ≈ $26.61 Million	₩-5.89 Billion ≈ $-3.99 Million	-0.150x	+17.34%
2021-12-31	₩41.69 Billion ≈ $28.25 Million	₩-7.56 Billion ≈ $-5.12 Million	-0.181x	+0.27%
2020-12-31	₩46.05 Billion ≈ $31.21 Million	₩-8.38 Billion ≈ $-5.68 Million	-0.182x	+12.97%
2019-12-31	₩24.76 Billion ≈ $16.78 Million	₩-5.17 Billion ≈ $-3.51 Million	-0.209x	-11.74%
2018-12-31	₩30.27 Billion ≈ $20.51 Million	₩-5.66 Billion ≈ $-3.84 Million	-0.187x	+54.45%
2017-12-31	₩9.07 Billion ≈ $6.15 Million	₩-3.72 Billion ≈ $-2.52 Million	-0.411x	-40.25%
2016-12-31	₩8.85 Billion ≈ $6.00 Million	₩-2.59 Billion ≈ $-1.76 Million	-0.293x	+0.24%
2015-12-31	₩3.58 Billion ≈ $2.42 Million	₩-1.05 Billion ≈ $-710.94K	-0.293x	--

About T&R Biofab Co. Ltd

KQ:246710 Korea Medical Devices

Market Cap

$36.88 Million

₩54.42 Billion KRW

Market Cap Rank

#22824 Global

#1507 in Korea

Share Price

₩1784.00

Change (1 day)

+4.57%

52-Week Range

₩1194.00 - ₩4535.00

All Time High

₩44150.00